Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.76
-1.24 (-11.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 60 employees as of December 31, 2024. The number of employees decreased by 6 or -9.09% compared to the previous year.
Employees
60
Change (1Y)
-6
Growth (1Y)
-9.09%
Revenue / Employee
$81,733
Profits / Employee
-$2,896,650
Market Cap
357.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Silence Therapeutics | 88 |
| Immuneering | 53 |
| X4 Pharmaceuticals | 45 |
| Surrozen | 44 |
| DiaMedica Therapeutics | 35 |
| Avalo Therapeutics | 33 |
ARMP News
- 1 day ago - Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. - PRNewsWire
- 4 weeks ago - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 - PRNewsWire
- 3 months ago - Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus - PRNewsWire
- 5 months ago - Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST - PRNewsWire
- 5 months ago - Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California - PRNewsWire